www.csl.com Open in urlscan Pro
12.3.33.229  Public Scan

Submitted URL: http://www.cslbehring.co.il/
Effective URL: https://www.csl.com/
Submission: On August 26 via api from US — Scanned from DE

Form analysis 2 forms found in the DOM

GET /search

<form method="GET" action="/search" role="search" aria-label="inline search">
  <label class="search-control-label">Search</label>
  <div class="ui-component ui-input search large" data-type="text" data-name="ui-input" cid="ui-input-2543-5404">
    <button data-role="search" tabindex="0" aria-label="search" type="button"></button>
    <input type="text" name="q" value="" placeholder="Search" aria-label="Search" autocomplete="off">
    <button data-role="submit" tabindex="0" aria-label="submit" type="submit"></button>
  </div>
</form>

GET /search

<form method="GET" action="/search" role="search" aria-label="modal search dialog">
  <label class="search-control-label">Search</label>
  <div class="ui-component ui-input search large" data-type="text" data-name="ui-input" cid="ui-input-2543-8672">
    <button data-role="search" tabindex="0" aria-label="search" type="button"></button>
    <input type="text" name="q" aria-label="Search" value="" placeholder="Search" autocomplete="off">
    <button data-role="submit" tabindex="0" aria-label="submit" type="submit"></button>
  </div>
</form>

Text Content

Skip to main content
 * Global Selector
 * 
 * Newsroom
 * Partnering
 * Contact

 * We Are CSL
   We Are CSL
   Our Businesses and Products
   Our Businesses and Products
   CSL Behring
   CSL Plasma
   CSL Seqirus
   CSL Vifor
   Vita: Original Stories
   CSL Podcasts
   Our Leadership
   Worldwide Locations
   Corporate Governance
   Corporate Governance
   Code of Responsible Business Practice
   Core Policies
   
   Vita means life. It's also our platform for sharing the stories of biotech's
   promise to patients and public health.
   
   Read the Stories
   
   CSL consists of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor. Learn
   more by visiting each section.
   
   Our Businesses and Products
   
 * Patients & Public Health
   Patients & Public Health
   Rare & Serious Diseases
   Rare & Serious Diseases
   Immunodeficiency and Autoimmune Diseases
   Hereditary Bleeding Disorders
   Hereditary Angioedema
   Alpha 1 Antitrypsin Deficiency
   Iron Deficiency
   Iron Deficiency
   Iron Deficiency Patient Stories
   Nephrology
   Nephrology
   Nephrology Patient Stories
   Vaccines
   Vaccines
   Pandemic Response
   In-Licensing
   Antivenoms and Q fever Vaccine
   Patient Support & Organizations
   Patient Support & Organizations
   CSL Behring USA Support & Assistance Programs
   CSL Vifor Managed Access Programs
   LEAD Grants
   
   Biotechnology leader CSL Behring offers the broadest range of quality
   plasma-derived and recombinant therapies in our industry.
   
   CSL Behring: Rare & Serious Diseases
   
   Derived from the expression 'securing health for all of us', CSL Seqirus is
   one of the world's largest influenza vaccine providers.
   
   CSL Seqirus: Vaccines
   
 * R&D
   R&D
   R&D Capabilities
   Awards, Grants and Initiatives
   World-Class R&D Network
   Product Pipeline
   Clinical Studies at CSL
   Clinical Studies at CSL
   Current Clinical Trials
   Research Practices
   How to Participate
   Clinical Studies FAQs
   
   R&D focuses its expertise on four strategic platforms: plasma protein
   technology; recombinant technology; cell and gene therapy; and vaccines
   technology.
   
   R&D Capabilities
   
   One of our core values at CSL is Innovation. We support collaborative
   innovation through the endowment of awards and grants to researchers around
   the world.
   
   Awards, Grants and Initiatives
   
 * Sustainability
   Sustainability
   Environment
   Environment
   Climate Resilience
   Energy and Emissions
   Waste, Water and Packaging
   Social
   Social
   Product Safety & Quality
   Innovation and R&D
   Access & Health Security
   Responsible & Resilient Supply Chain
   Sustainable Workforce
   Sustainable Workforce
   Providing A Positive Working Environment
   Health, Safety & Wellbeing
   Diversity, Equity & Inclusion
   Governance
   Governance
   Ethics & Transparency
   Data Protection & Privacy
   Stakeholder Engagement & Material Topics
   Data and Reporting Centre
   Data and Reporting Centre
   Annual Publications
   Policies
   Key Performance Data Summary
   
   As part of our broader sustainability strategy to build a more sustainable
   future, we've committed to a 40% reduction in absolute Scope 1 and 2
   emissions by 2030.
   
   Learn About Our Targets
   
   Along with our sustainability strategy, CSL’s community contribution
   framework helps deliver on our Values and support execution of our 2030
   strategy.
   
   Supporting Our Communities
   
 * Careers
   Careers
   Diversity, Equity & Inclusion
   How CSL Supports Your Well-being
   Early Careers at CSL
   Early Careers at CSL
   Apprenticeships
   Internships at CSL
   Graduate Rotational Programs at CSL
   
   At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission
   and who we are. It fuels our innovation day in and day out.
   
   Read About Our DE&I
   
   Whether you are early in your college education or recently completed your
   degree, it's never too soon to consider CSL for your Promising Future!
   
   Early Careers at CSL
   
 * Investors
 * 
 * 

CSL
Back
Search


 * 

 * We Are CSL
    * We Are CSL
    * Our Businesses and Products
       * Our Businesses and Products
       * CSL Behring
       * CSL Plasma
       * CSL Seqirus
       * CSL Vifor
   
    * Vita: Original Stories
    * CSL Podcasts
    * Our Leadership
    * Worldwide Locations
    * Corporate Governance
       * Corporate Governance
       * Code of Responsible Business Practice
       * Core Policies

 * Patients & Public Health
    * Patients & Public Health
    * Rare & Serious Diseases
       * Rare & Serious Diseases
       * Immunodeficiency and Autoimmune Diseases
       * Hereditary Bleeding Disorders
       * Hereditary Angioedema
       * Alpha 1 Antitrypsin Deficiency
   
    * Iron Deficiency
       * Iron Deficiency
       * Iron Deficiency Patient Stories
   
    * Nephrology
       * Nephrology
       * Nephrology Patient Stories
   
    * Vaccines
       * Vaccines
       * Pandemic Response
       * In-Licensing
       * Antivenoms and Q fever Vaccine
   
    * Patient Support & Organizations
       * Patient Support & Organizations
       * CSL Behring USA Support & Assistance Programs
       * CSL Vifor Managed Access Programs
       * LEAD Grants

 * R&D
    * R&D
    * R&D Capabilities
    * Awards, Grants and Initiatives
    * World-Class R&D Network
    * Product Pipeline
    * Clinical Studies at CSL
       * Clinical Studies at CSL
       * Current Clinical Trials
       * Research Practices
       * How to Participate
       * Clinical Studies FAQs

 * Sustainability
    * Sustainability
    * Environment
       * Environment
       * Climate Resilience
       * Energy and Emissions
       * Waste, Water and Packaging
   
    * Social
       * Social
       * Product Safety & Quality
       * Innovation and R&D
       * Access & Health Security
       * Responsible & Resilient Supply Chain
   
    * Sustainable Workforce
       * Sustainable Workforce
       * Providing A Positive Working Environment
       * Health, Safety & Wellbeing
       * Diversity, Equity & Inclusion
   
    * Governance
       * Governance
       * Ethics & Transparency
       * Data Protection & Privacy
       * Stakeholder Engagement & Material Topics
   
    * Data and Reporting Centre
       * Data and Reporting Centre
       * Annual Publications
       * Policies
       * Key Performance Data Summary

 * Careers
    * Careers
    * Diversity, Equity & Inclusion
    * How CSL Supports Your Well-being
    * Early Careers at CSL
       * Early Careers at CSL
       * Apprenticeships
       * Internships at CSL
       * Graduate Rotational Programs at CSL

 * Investors
 * Newsroom
 * Partnering
 * Contact
 * Global Selector
 * 


OUR NEW HOME IN MELBOURNE

CSL’s new Global Headquarters and Centre for Research and Development in
Australia places us in the heart of the Parkville biomedical precinct, and
houses seven floors of world-class medical research laboratories to enable us to
collaborate on life-changing therapies for patients.

Watch video


We have released our 2023 Annual Report Click here to read the Annual Report →

CSL
CSL Behring
CSL Plasma
CSL Seqirus
CSL Vifor

CSL. ALWAYS EVOLVING FOR A BETTER WORLD.

CSL has delivered biotechnology excellence for over a century. Today, with the
combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s
offerings are more diverse than ever to help ensure patients and people
everywhere get the treatments they need. We’re always improving so life can,
too.

Our Businesses and Products

CSL BEHRING. LEADING THE WAY IN TREATING RARE AND SERIOUS DISEASES.

CSL Behring is a global biotech leader with a broad range of biotherapies for
rare and serious diseases including bleeding disorders, immunodeficiencies,
hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin
Deficiency.

More About CSL Behring

CSL PLASMA. HELPING THOSE IN NEED LIVE HEALTHIER LIVES.

CSL Plasma operates one of the world’s largest and most sophisticated plasma
collection networks, with more than 300 plasma collection centers in the U.S.,
Europe and China. The plasma collected is used by CSL Behring for the purpose of
manufacturing and delivering its life-saving therapies to people in more than
100 countries.

More About CSL Plasma

CSL SEQIRUS. ON THE FRONT LINE OF PUBLIC HEALTH PROTECTION.

As the only vaccine company with a singular global focus on influenza, we work
tirelessly on cutting-edge research, transformative technologies, and the latest
methods of production and distribution. Together with our partners we’re on the
front line every day, working to help protect communities from seasonal
influenza and global pandemic threats.

More About CSL Seqirus

CSL VIFOR. CHANGING THE GAME IN IRON DEFICIENCY AND NEPHROLOGY.

The newest member of the CSL family, CSL Vifor is a global leader in iron
deficiency and nephrology and is committed to launching the next generation of
therapies to truly address the full spectrum of kidney disease, with a focus on
dialysis and rare disease.

More About CSL Vifor
CSL Logo The text 'CSL' in bold white all capitals.
CSL Behring Logo The text 'CSL Behring' in bold white.
CSL Plasma Logo The text 'CSL Plasma' in bold white.
CSL Seqirus Logo The text 'CSL Seqirus' in bold white.
CSL Vifor Logo The text 'CSL Vifor' in bold white.

CSL. ALWAYS EVOLVING FOR A BETTER WORLD.

CSL has delivered biotechnology excellence for over a century. Today, with the
combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s
offerings are more diverse than ever to help ensure patients and people
everywhere get the treatments they need. We’re always improving so life can,
too.

Our Businesses and Products

CSL BEHRING. LEADING THE WAY IN TREATING RARE AND SERIOUS DISEASES.

CSL Behring is a global biotech leader with a broad range of biotherapies for
rare and serious diseases including bleeding disorders, immunodeficiencies,
hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin
Deficiency.

More About CSL Behring

CSL PLASMA. HELPING THOSE IN NEED LIVE HEALTHIER LIVES.

CSL Plasma operates one of the world’s largest and most sophisticated plasma
collection networks, with more than 300 plasma collection centers in the U.S.,
Europe and China. The plasma collected is used by CSL Behring for the purpose of
manufacturing and delivering its life-saving therapies to people in more than
100 countries.

More About CSL Plasma

CSL SEQIRUS. ON THE FRONT LINE OF PUBLIC HEALTH PROTECTION.

As the only vaccine company with a singular global focus on influenza, we work
tirelessly on cutting-edge research, transformative technologies, and the latest
methods of production and distribution. Together with our partners we’re on the
front line every day, working to help protect communities from seasonal
influenza and global pandemic threats.

More About CSL Seqirus

CSL VIFOR. CHANGING THE GAME IN IRON DEFICIENCY AND NEPHROLOGY.

The newest member of the CSL family, CSL Vifor is a global leader in iron
deficiency and nephrology and is committed to launching the next generation of
therapies to truly address the full spectrum of kidney disease, with a focus on
dialysis and rare disease.

More About CSL Vifor


VITA: ORIGINAL STORIES

'Vita' means life. It's also where we share the stories of biotech's promise to
patients and public health.


5 THINGS TO KNOW ABOUT THE NATIONAL BLEEDING DISORDERS FOUNDATION

23 Aug 2023

The National Hemophilia Foundation changed its name and officially broadened its
mission to include all bleeding disorders.

5 Fast Facts


A MUST FOR PARENTS OF COLLEGE STUDENTS

22 Aug 2023

Before they head to campus, students who want a parent’s help managing a chronic
health condition should take steps to get medical paperwork in order.

What the Experts Say


CSL NAMES FIRST CHIEF SUSTAINABILITY OFFICER

21 Aug 2023

Furthering its commitment to a healthier world, CSL appointed Jeffrey Ball to
head sustainability initiatives at CSL.

Learn About His Role


CAREERS AT CSL

We are committed to helping employees fulfill their career aspirations while
working in a values-based culture. Are you next?

Promising Futures at CSL

CSL on LinkedIn
Follow us!
25 Aug

CSL's Jennifer Maroon is a survivor and a competitor. During the workday, she's
a Customer Account Analyst Manager for CSL Seqirus, but off the clock, you'll
find Jennifer out on the water with a paddle in her hands and a drum beat in her
ears. Find out how she found community with fellow breast cancer survivors and
how the sport of Dragon Boating taught her the five keys to her personal
success. Vita Link: https://bit.ly/45G92HJ #CSLSeqirus #DrivenByOurPromise
#DragonBoat #BreastCancerSurvivor

25 Aug

After a successful 75 years, this U.S. patient group has a new name and an
officially expanded mission to represent all patients who live with bleeding
disorders. https://bit.ly/3KWaz4G

24 Aug

Exciting News! CSL is thrilled to partner with Pride in Diversity Australia
https://bit.ly/3Lj1sv5, fostering inclusive workplaces. Together, we champion
diversity and create a more welcoming future. #PromisingFutures
#PrideInDiversity


24 Aug

Friday, 25 August is Wear it Purple Day in Australia. This day is all about
celebrating and supporting young LGBTQIA + people and striving to foster
supportive, inclusive and safe environments for rainbow young people. CSL is
committed to building a workplace where employees are respected, valued and able
to freely share their perspectives experiences and ideas. During the week, CSL
employees showed their support by wearing WIP wristbands, wearing purple to work
and employees attended a fireside chat with our special guest speaker Sarah
Trombetta, Board Director for Wear it Purple who shared her own personal
experience and how we can be an effective ally for LGBTQIA + young people. #CSL
#wearitpurple #wearitpurpleday #WIPD2023 #WIPD23 #Melbourne


23 Aug

At CSL, you can take real ownership of your career. With our Employee Share
Purchase Plan, you’ll share in the growth and success of CSL by purchasing
company shares at a minimum 15% discount. It’s the opportunity to achieve your
own Promising Future while enabling Promising Futures for millions of people
around the world. Learn more. https://bit.ly/45mtU70

23 Aug

Emily, a 13-year-old from Las Vegas, is living with congenital afibrinogenemia,
an ultra-rare hereditary bleeding disorder that affects just 1 in 1 million
newborns. Watch the video and learn more about her inspiring journey:
bit.ly/43TUALL. #CongenitalAfibrinogenemia


22 Aug

For graduates interested in Manufacturing, Finance or Engineering, CSL’s
Australian Graduate Program lays a strong foundation for an amazing career.
Apply for our 2024 intake before 27 August. https://bit.ly/3P84ep4
#PromisingFutures #GraduateProgram #DoWorkThatMatters

21 Aug

CSL’s new Global Headquarters and Centre for Research and Development places us
in the heart of the Parkville biomedical precinct, and houses seven floors of
world-class medical research laboratories to enable us to collaborate on
life-changing therapies for patients.

22 Aug

CSL Vifor is attending the ESC Congress taking place between August 25 to 28 in
Amsterdam, Netherlands. It is the event where cardiologists and researchers from
around the world join forces with colleagues and peers to share valuable
information and learn from each other. We look forward to seeing you there! Find
out more about the ESC congress here: https://bit.ly/3E46KGy #cslvifor #esc2023
#nephrology #irondeficiency #hyperkalemia

21 Aug

CSL recognises the amazing role of donors in protecting public health, and
recently we met with one extraordinary donor - this king brown snake! 🐍 By
donating its venom – it’s helping save lives. Our CSL Seqirus team was invited
to observe the venom sourcing program at Australian Reptile Park . The program
provides critical venom to help produce antivenoms. We give our sincere thanks
to the animal handlers for their dedication and contribution to helping protect
public health. Learn more about how you can be better prepared for Australian
bites and stings here: https://bit.ly/3QIIEc0 #CSLSeqirus #DrivenByOurPromise
#Antivenom #Australia #AustralianReptilePark #KingBrownSnake


WE ARE CSL

 * Our Businesses and Products

 * Vita: Original Stories

 * CSL Podcasts

 * Our Leadership

 * Worldwide Locations

 * Corporate Governance


PATIENTS & PUBLIC HEALTH

 * Rare & Serious Diseases

 * Iron Deficiency

 * Nephrology

 * Vaccines

 * Patient Support & Organizations


R&D

 * R&D Capabilities

 * Awards, Grants and Initiatives

 * World-Class R&D Network

 * Product Pipeline

 * Clinical Studies at CSL


SUSTAINABILITY

 * Environment

 * Social

 * Sustainable Workforce

 * Governance

 * Data and Reporting Centre


CAREERS

 * Diversity, Equity & Inclusion

 * How CSL Supports Your Well-being

 * Early Careers at CSL


INVESTORS

Terms of Use Cookie Policy Global Privacy Policy Accessibility Statement
Glossary Sitemap
 * Terms of Use
 * Cookie Policy
 * Global Privacy Policy
 * Accessibility Statement
 * Glossary
 * Sitemap

© 2023 CSL, All Rights Reserved

 * 
 * 
 * 
 * 
 * 

Search


 * 


Play
PausePlay
Seek% buffered00:00
UnmuteMuteDisable captionsEnable captionsExit fullscreenEnter fullscreen
CSL
 * CSL (CSL Behring's Parent Company)

CSL Behring Worldwide

Americas

 * Argentina
 * Brazil
 * Canada
 * Chile
 * Colombia
 * CSL Behring Global
 * Mexico

Asia Pacific

 * Australia
 * China
 * Japan
 * Korea
 * Singapore
 * Taiwan

Middle East

 * Saudi Arabia
 * United Arab Emirates (MEA)

Europe

 * Austria
 * Belgium and Luxembourg
 * Czech Republic
 * Denmark
 * Finland
 * France
 * Germany
 * Greece
 * Hungary
 * Iceland
 * Italy
 * Netherlands
 * Norway
 * Poland
 * Slovakia
 * Spain
 * Sweden
 * Switzerland
 * Turkey
 * United Kingdom

CSL Plasma (CSL Behring Subsidiary)
 * CSL Plasma US
 * CSL Plasma Germany
 * CSL Plasma Hungary

By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts.

Cookies Settings Reject All Accept All Cookies



PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
More information
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

View Vendor Details‎

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

View Vendor Details‎

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

View Vendor Details‎

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

View Vendor Details‎
Back Button


VENDORS LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Reject All Confirm My Choices